%D8%A7%D8%B6%D8%B7%D8%B1%D8%A7%D8%A8_%D9%86%D9%88%D9%85_%D8%AD%D8%B1%D9%83%D8%A9_%D8%A7%D9%84%D8%B9%D9%8A%D9%86_%D8%A7%D9%84%D8%B3%D8%B1%D9%8A%D8%B9%D8%A9_%D8%A7%D9%84%D8%B3%D9%84%D9%88%D9%83%D9%8AREM-Schlaf-Verhaltensst%C3%B6rungRapid_eye_movement_sleep_behavior_disorderTrouble_du_comportement_en_sommeil_paradoxal%E3%83%AC%E3%83%A0%E7%9D%A1%E7%9C%A0%E8%A1%8C%E5%8B%95%E9%9A%9C%E5%AE%B3RemslaapgedragsstoornisZaburzenia_zachowania_podczas_snu_REMQ2103933
about
sameAs
Mike BirbigliaNorth American Prodromal Synucleinopathy ConsortiumDaTSCAN Imaging in Aging and Neurodegenerative DiseaseGut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's DiseaseAdrenergic Blockers for Cardiac Changes in Early Parkinson's DiseaseFamilial Aggregation and Biomarkers in REM Sleep Behaviour Disorder.Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and ParkinsonismBrain Imaging in the Idiopathic REM Sleep Behavior Disorder (ALICE)MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.Prodromal Markers of First-degree Relatives of Patients With Psychiatric Disorders Comorbid With RBDExploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior DisorderQuantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and ControlsEstablish a National Registry of REM Sleep Behavior DisorderProgression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBDStudy to Determine Whether Ramelteon Helps People With REM Sleep Behavior DisorderSubcortical Oscillations in Human Sleep DysregulationRBD Longitudinal as Prognostic for PDInvestigation of Clinical Feature and Brain Function in Narcoleptic PatientsStriatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for NeurodegenerationUltra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's DiseaseEfficacy and Safety of Melatonin and Clonazepam for IRBD: Cross-over StudyGait and REM Sleep Behavior DisorderMotor Control During Rapid Eye Movement (REM) Sleep Behaviour DisorderNatural History Study of SynucleinopathiesUnderstanding the Natural History of REM Sleep Behavior DisorderStudy Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)Detecting Parkinson's Disease Through Speech AnalysisTreatment of REM Sleep Behavior Disorder (RBD) With Sodium OxybateEvolution of RBD in PDProspective Neuroimaging Investigation of Idiopathic REM Sleep Behavior DisorderOpen-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderSearch for Biomarkers of Neurodegenerative Diseases in Idiopathic REM Sleep Behavior DisorderEffect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot StudyEfficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson DiseaseRetinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson DiseaseExploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior DisorderEffect of Clonazepam on REM Sleep Behavior Disorder in Patients With ParkinsonismA Study of Efficacy and Safety of Idebenone vs. Placebo in Prodromal Parkinson DiseaseFrench Validation of a Severity Scale in REM Sleep Behavior Disorder (SEV-TCSP)Cardiac Changes in Early Parkinson's Disease: A Follow up Study
P1050
P1855
Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's diseaseInsulinoma Masquerading as Rapid Eye Movement Sleep Behavior Disorder: Case Series and Literature ReviewBehavioural and Cognitive-Behavioural Treatments of Parasomnias.Relationships between Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: Clinical Assessments, Biomarkers, and Treatment.Parkinsonism Risk Factors in Salt Lake City, Utah: A Community-Based StudyREM-Sleep Behavior Disorder in Patients With Essential Tremor: What Is Its Clinical Significance?
P921
Q5576465-f234c14a-4f94-bbbd-4b64-597d07762eaeQ61902369-1A6F0541-2F24-4634-94D3-D0481F2217C3Q61966952-54C9E309-0867-467E-BFE0-2AE0FA994EE0Q62025843-64F128F6-2856-4961-90D8-93571B3F4C04Q62030923-25E27EA0-5214-4E3D-B2EA-A62129AE52DCQ62062326-E48FD54A-915C-4442-BE7A-D6BBC7FAFDDEQ63062281-28669920-6D94-45AD-B7B1-382B2AE38809Q63228907-5377A8FE-5C04-4A20-B5B4-B384DF8D59EEQ63316650-12F3B150-C9B7-4AC2-AA22-68169EC39F79Q63394686-07D0CF07-3242-449B-A48E-5DCC310EE5FFQ63401866-88E322CE-2753-42E4-A2AE-74A94BC91CDBQ63597246-CC59417C-9C77-4422-816B-FCBA454EE755Q63598387-00C9D3F7-738D-4FDB-96A2-0D1F9E698AC5Q63598393-FD3DFF5F-CE68-487A-8DB8-27151BDB1CCFQ63807259-31BFC180-66FD-44BD-BA63-F8980C9DD45FQ64185429-B5AED913-DB28-4A7F-9371-676B4078EAF0Q64695608-33D16F04-2CBC-46E9-9E43-7F7E4724FD76Q64805422-E8E3C697-DF7F-4F1E-87A4-89B368F023F0Q64808343-FB6785E1-3946-4C3A-B84C-1A7745BBA7DAQ64817288-9077C301-EF2A-47DB-ABA2-C543B1D896AFQ64837589-6FB3259E-2FF5-4916-9849-3FC0E83AE185Q65331334-7E0E5221-C753-42E7-AADF-89AF93C62CF8Q65361726-02FDAECA-DB7B-45DB-96A3-5FC2A0D615B2Q65368749-F1F3E442-4316-4C3C-954F-96C766899EA3Q65371566-22DE9E2B-EF64-4891-80B5-4BEE1DDA9E25Q65394893-9748BD4D-68E8-43A5-B650-AAF2251553DDQ66044124-9535C726-1D02-4BF0-BE61-15D1218AFDACQ66063526-14067931-0891-4897-81B8-5439012DF3E9Q66073615-0BB39D70-DA03-400D-AF4B-2AADC29346E2Q66077001-4A5CE76E-0B35-42CE-BB61-C3B50396A642Q66083921-5102F8C8-1422-4D2D-B1E2-4162525A0147Q66387479-18A06D9C-3E36-478E-BCF7-938F7D3E45FBQ66399651-BF80EBAA-91B0-4225-8EFB-29462084F074Q66402369-7117F55A-CE26-48D7-9FF2-8243CD2FE65AQ66409413-CAE66831-77F9-4B61-A5F2-74FE9A51707AQ66546405-F127AE6E-E0F8-4D58-927F-9B99454D662AQ67133863-98892BD0-2775-4677-B726-84B9D2F40F5FQ74272181-7656D43F-6DB9-4497-AD4F-8DDF81003E1DQ74286727-D61353F8-AFD9-43B2-AF89-728E0FCFA66AQ83794864-AAB83A7D-AEAD-48AF-861A-417EBD6E0DF9
P1050
description
Krankheit
@de
disturbo del sonno che avviene durante la fase REM
@it
pathologie causant des mouvement vifs et souvent violents pendant le sommeil
@fr
porucha spánku
@cs
sleep disorder that involves a ...... phase with rapid eye movement
@en
name
REM sleep behavior disorder
@en
REM-Schlaf-Verhaltensstörung
@de
REM睡眠行为障碍
@zh-cn
REM睡眠行为障碍
@zh-hans
REM睡眠行為障礙
@zh-hant
Remslaapgedragsstoornis
@nl
Zaburzenia zachowania podczas snu REM
@pl
disturbo comportamentale del sonno REM
@it
trouble du comportement en sommeil paradoxal
@fr
اضطراب نوم حركة العين السريعة السلوكي
@ar
type
label
REM sleep behavior disorder
@en
REM-Schlaf-Verhaltensstörung
@de
REM睡眠行为障碍
@zh-cn
REM睡眠行为障碍
@zh-hans
REM睡眠行為障礙
@zh-hant
Remslaapgedragsstoornis
@nl
Zaburzenia zachowania podczas snu REM
@pl
disturbo comportamentale del sonno REM
@it
trouble du comportement en sommeil paradoxal
@fr
اضطراب نوم حركة العين السريعة السلوكي
@ar
altLabel
Disturbo RBD
@it
REM睡眠行为障碍
@zh
Rapid eye movement sleep behavior disorder
@en
Rapid eye movement sleep behaviour disorder
@de
Schenk-Syndrom
@de
Troubles du comportement en sommeil paradoxal
@fr
prefLabel
REM sleep behavior disorder
@en
REM-Schlaf-Verhaltensstörung
@de
REM睡眠行为障碍
@zh-cn
REM睡眠行为障碍
@zh-hans
REM睡眠行為障礙
@zh-hant
Remslaapgedragsstoornis
@nl
Zaburzenia zachowania podczas snu REM
@pl
disturbo comportamentale del sonno REM
@it
trouble du comportement en sommeil paradoxal
@fr
اضطراب نوم حركة العين السريعة السلوكي
@ar
P486
P6366
P646
P1417
topic/REM-sleep-behaviour-disorder
P1995
P279
P2892
P31
P4229
P486
P5270
MONDO:0005937
P6366
2910387360
P646
P672
C10.886.659.633.700